(15132371), P. A., (21904586), M. G., (21904589), K. M., (21904592), H. Q., (21904595), R. P., (21904598), A. F., . . . (21904616), A. O. (2025). Supplementary Figure 1 from A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.
Citace podle Chicago (17th ed.)(15132371), Parul Agarwal, et al. Supplementary Figure 1 from A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma. 2025.
Citace podle MLA (9th ed.)(15132371), Parul Agarwal, et al. Supplementary Figure 1 from A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma. 2025.